Still in hot water over its “phantom recall” of a Motrin product, Johnson & Johnson looks to expand its share of the vaccine market with purchase of Dutch pharma company Crucell.
Continue reading Johnson & Johnson Plans to Buy Vaccine Maker Crucell
Johnson & Johnson Plans to Buy Vaccine Maker Crucell originally appeared on DailyFinance on Fri, 17 Sep 2010 08:00:00.
Filed Under: Company News, Health Care, Johnson & Johnson, Stocks in the News